Fermín Ignacio Milagro Yoldi-rekin lankidetzan egindako argitalpenak (32)

2024

  1. Anti-Obesity Effects of a Collagen with Low Digestibility and High Swelling Capacity: A Human Randomized Control Trial

    Nutrients , Vol. 16, Núm. 20

  2. Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment

    Journal of Physiology and Biochemistry

  3. Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial

    Clinical Nutrition, Vol. 43, Núm. 7, pp. 1770-1781

2023

  1. Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease

    Journal of Physiology and Biochemistry

2022

  1. A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers

    Panminerva medica, Vol. 64, Núm. 4, pp. 485-496

  2. Possible metabolic interplay between quality of life and fecal microbiota in a presenior population–Preliminary results

    Nutrition, Vol. 103-104

2021

  1. Changes in miRNA expression with two weight-loss dietary strategies in a population with metabolic syndrome

    Nutrition, Vol. 83

  2. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study

    European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3043-3057

  3. Three different genetic risk scores based on fatty liver index, magnetic resonance imaging and lipidomic for a nutrigenetic personalized management of nafld: The fatty liver in obesity study

    Diagnostics, Vol. 11, Núm. 6

2020

  1. Association of the SH2B1 RS7359397 gene polymorphism with steatosis severity in subjects with obesity and non-alcoholic fatty liver disease

    Nutrients, Vol. 12, Núm. 5

2019

  1. An integrated transcriptomic and epigenomic analysis identifies CD44 gene as a potential biomarker for weight loss within an energy-restricted program

    European Journal of Nutrition, Vol. 58, Núm. 5, pp. 1971-1980

  2. Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: A comparison with healthy controls

    Nutrients, Vol. 11, Núm. 2

  3. Associations between olfactory pathway gene methylation marks, obesity features and dietary intakes

    Genes and Nutrition, Vol. 14, Núm. 1

  4. MiR-1185-1 and miR-548q are biomarkers of response to weight loss and regulate the expression of GSK3B

    Cells, Vol. 8, Núm. 12

2018

  1. Association of low dietary folate intake with lower CAMKK2 gene methylation, adiposity, and insulin resistance in obese subjects

    Nutrition Research, Vol. 50, pp. 53-62

  2. DNA methylation patterns at sweet taste transducing genes are associated with BMI and carbohydrate intake in an adult population

    Appetite, Vol. 120, pp. 230-239

  3. Dopamine gene methylation patterns are associated with obesity markers and carbohydrate intake

    Brain and Behavior, Vol. 8, Núm. 8

  4. Implication of miR-612 and miR-1976 in the regulation of TP53 and CD40 and their relationship in the response to specific weight-loss diets

    PLoS ONE, Vol. 13, Núm. 8

2016

  1. DNA Methylation and Hydroxymethylation Levels in Relation to Two Weight Loss Strategies: Energy-Restricted Diet or Bariatric Surgery

    Obesity Surgery, Vol. 26, Núm. 3, pp. 603-611

  2. Expression of inflammation-related miRNAs in white blood cells from subjects with metabolic syndrome after 8 wk of following a Mediterranean diet-based weight loss program

    Nutrition, Vol. 32, Núm. 1, pp. 48-55